PAYC · Paycom Software, Inc. · Stock research

Current Thesis

The leg being bought is operating leverage, not growth reacceleration. Paycom's Q2 2026 print (released after the close on 2026-08-05) delivered revenue of $531.2M against a $513.101M consensus and non-GAAP diluted EPS of $2.78 against $2.38, and management raised the FY26 revenue range to $2.197–2.212B from $2.175–2.195B. Nine sell-side targets were lifted on 2026-08-06 and 2026-08-07. What the market is paying for is the combination of ~46% full-year adjusted EBITDA margin at the company's own guided midpoint, mid-single-digit-to-high-single-digit recurring revenue growth, and a share count being actively shrunk — The complication is entry: the stock closed 2026-08-07 at $214.94 with RSI(14) at 81.0 after a 57.5% three-month advance, and the median of those nine freshly raised targets is $210.

Bullish and bearish views on Paycom Software, Inc.

The model's bull view on Paycom Software, Inc. (PAYC), in brief: Q2 2026 beat on both lines (2026-08-05): total revenue $531.2M, +9.8% YoY from $483.6M, versus $513.101M consensus. The bear view: The guide embeds H2 deceleration. Q2 total revenue grew 9.8% and recurring grew 11.0%; the company frames FY26 as approximately 7–8% total growth and 8–9% recurring growth. Arithmetic on the company's own framing points to slower second-half growth than the quarter just… Both cases follow in full.

Bull Case

• Q2 2026 beat on both lines (2026-08-05): total revenue $531.2M, +9.8% YoY from $483.6M, versus $513.101M consensus. Recurring and other revenue $505.2M, +11.0% YoY, 95.1% of total — the annuity base grew faster than the reported top line.
• Profitability ahead of the model: adjusted EBITDA $235.0M at a 44.2% margin; GAAP net income $107.4M ($2.34 per diluted share); non-GAAP diluted EPS $2.78 versus a $2.38 estimate.
• Guide raised, not just met: the new FY26 low end ($2.197B) sits above the old high end ($2.195B). FY26 adjusted EBITDA guided to $1.007–1.022B, which the company frames as roughly a 46% margin at the midpoint — above the 44.2% just printed, so H2 carries the expansion.
• A quarterly dividend of $0.375 was declared 2026-08-03, record 2026-08-24, payable 2026-09-08.
• Coverage repriced in one session: on 2026-08-06, KeyBanc went to $270 (Overweight), TD Cowen $244 (Buy), BTIG $230 (Buy), Guggenheim $225 (Buy), Barclays $210 (Equal-Weight), UBS $205 (Buy), Stifel $200 (Hold), Cantor $195 (Neutral); Citigroup followed on 2026-08-07 at $194 (Neutral).
• No insider distribution surfaced into the move: the most recent CEO Form 4 activity found is a 25,000-share bona fide gift dated 2026-06-15, after which Chad Richison held 2,774,921 shares directly. No equity issuance accompanied the run.

Bear Case

• The guide embeds H2 deceleration. Q2 total revenue grew 9.8% and recurring grew 11.0%; the company frames FY26 as approximately 7–8% total growth and 8–9% recurring growth. Arithmetic on the company's own framing points to slower second-half growth than the quarter just delivered.
• The raise is small next to the beat. Q2 revenue exceeded consensus by a visible margin, yet the full-year low end moved only just past the prior high end. That pattern is consistent with flowing the quarter through rather than upgrading H2 assumptions.
• Price is through most of the new targets. Five of the nine targets raised on 2026-08-06/07 — Citi $194, Cantor $195, Stifel $200, UBS $205, Barclays $210 — sit at or below the 2026-08-07 close of $214.94. Median of the nine is $210.
• Ratings did not follow the numbers. Citigroup (Neutral), Cantor (Neutral), Stifel (Hold) and Barclays (Equal-Weight) all maintained their stance while raising the target — the target moves are mark-to-market, not upgrades.
• Margin help may be partly discretionary. A third-party summary of the quarter (Pulse2, 2026-08-05) attributed the profit outperformance to recurring growth, margin expansion, lower research spending, and a reduced share count. Cost restraint compounds differently than product-driven leverage.
• Buyback funding is tighter. Cash and equivalents fell to $198.0M from $370.0M at 2025 year-end after the Q2 repurchase. Sustaining a $345.9M-per-quarter pace from balance-sheet cash is a different proposition at $198.0M.
• Extension. RSI(14) 81.0 and +57.5% over three months as of 2026-08-07, with the next scheduled company event roughly 90 days out.

Setup & Price Structure

Last completed daily close $214.94 (2026-08-07), 7.2% below the 52-week high of $231.71, three-month return +57.5%, RSI(14) 81.0. The name gapped higher on 2026-08-06 — Benzinga reported shares indicated +14.1% pre-market — and has held the bulk of that gap through the following session.

Life-cycle: ACCELERATING. What dates it: the attention arrived on 2026-08-06, when nine brokers moved targets in a single session off the 2026-08-05 print, and the stock's move that day put it into multiple intraday-mover screens. New estimates, new headlines, expanding participation. That is an early-leg signature, but the crowding evidence is the kind that shows up in the back half of one: an RSI in the low 80s, a majority of the freshly raised targets below spot, and a first resistance shelf at the 52-week high $231.71 that has not been tested since the print.

Observables on positioning, stated without a verdict: no secondary or convertible issuance accompanied the advance; the company was the buyer of size in the quarter ($345.9M); insider activity in the last 60 days that surfaced is a gift, not an open-market sale; the next earnings date does not fall inside 30 days, so there is no imminent binary compressing the setup.

Catalyst Calendar (next 30 days)

• 2026-08-24 — record date for the $0.375/share quarterly dividend declared 2026-08-03. Mechanical; resolves nothing about the growth or margin thesis.
• 2026-09-08 — dividend payment date (just past the 30-day window).
• ~2026-11-04 (est.) — Q3 2026 results. Paycom has historically reported Q3 in the first week of November; the date is not yet confirmed. This is the first event that tests whether the 8–9% FY26 recurring guide is a floor and whether H2 adjusted EBITDA margin clears the 44.2% printed in Q2.

There is no company-scheduled event inside 30 days that resolves the thesis. That vacuum is itself the structural feature of the setup: the narrative has to be carried by flow and estimate revision for roughly three months before the next hard datapoint.

What Would Change Our Mind

The thesis stands on two numbers holding. First, recurring revenue growth of 8–9% has to behave as a floor rather than a ceiling; a Q3 print (~2026-11-04, est.) that trims that range removes the growth backstop under the margin story and leaves the buyback carrying EPS alone. Second, FY26 adjusted EBITDA margin has to expand toward the guided ~46% midpoint — a Q3 adjusted EBITDA margin at or below the 44.2% delivered in Q2 would contradict the operating-leverage claim the re-rating is priced on.

On structure: a weekly close below $195 would put price back under every one of the nine targets raised on 2026-08-06/07 and surrender the post-print advance, which would read as the market rejecting the guidance raise rather than digesting it. A cash balance that falls materially below the $198.0M reported at quarter-end without a corresponding debt facility would also mark the repurchase pace as unsustainable at Q2's level.

If the theme flips to SATURATED — a second wave of coverage arriving with no accompanying estimate revision — the accelerating label above stops applying and the crowding observables become the dominant read.

Correlation Notes

• Mid-market HCM cohort. Trades with Paylocity (PCTY) and, less tightly, ADP and Paychex (PAYX). A guidance disappointment from a direct comp on mid-market unit growth reads across directly, since all four sell per-employee-per-month.
• US mid-market employment. Revenue scales with employees on customer payrolls, so monthly nonfarm payrolls and small/mid-business headcount data feed the recurring line with a lag. Headcount contraction at existing clients hits revenue without any logo churn.
• Short-term rates. Interest earned on funds held for clients is a rate-sensitive revenue component for every payroll processor; a cutting cycle compresses it, and a repricing of the front end is a shared factor across the group regardless of unit growth.
• Software factor beta. A high-margin, high-multiple SaaS name moves with the broad software complex on rate-driven multiple swings; on 2026-08-06 the tape itself was mixed (S&P 500 and Dow lower on a 4% Brent move), so the +14.1% indicated gap was idiosyncratic rather than beta.